about
An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatmentMyeloid neoplasias: what molecular analyses are telling usUp-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signalingMolecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade.FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia.Applications of microarray technology to Acute Myelogenous LeukemiaThe clinical development of FLT3 inhibitors in acute myeloid leukemia.Development and Characterization of FLT3-Specific Curcumin-Loaded Polymeric Micelles as a Drug Delivery System for Treating FLT3-Overexpressing Leukemic Cells.Genetic stratification in myeloid diseases: from risk assessment to clinical decision support tool.FLT3-ITD and its current role in acute myeloid leukaemia.Isolation of human mAbs that directly modulate FMS-related tyrosine kinase 3 signaling.NPM1, FLT3 and CEBPA mutations in pediatric patients with AML from Argentina: incidence and prognostic value.Prognostic significance of NPM1 mutations in acute myeloid leukemia: A meta-analysis.The antitumor compound triazoloacridinone C-1305 inhibits FLT3 kinase activity and potentiates apoptosis in mutant FLT3-ITD leukemia cells.Combining the FLT3 inhibitor PKC412 and the triterpenoid CDDO-Me synergistically induces apoptosis in acute myeloid leukemia with the internal tandem duplication mutationPrognostic significance of the FLT3 ITD mutation in patients with normal-karyotype acute myeloid leukemia in relapse.FLT3 INHIBITORS: RECENT ADVANCES AND PROBLEMS FOR CLINICAL APPLICATION.Refining the diagnosis and prognostic categorization of acute myeloid leukemia patients with an integrated use of cytogenetic and molecular studies.Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis.Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.Detection of FLT3/TKD and IDH1 Mutations in Pakistani Acute Myeloid Leukemia Patients by Denaturing HPLC.Case study interpretation--Fort Lauderdale: Case 3.Prognostic impact of low allelic ratio ITD and mutation in acute myeloid leukemiaPrognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group
P2860
Q27027207-2D98D0F6-86B7-4178-8EB2-6316B9D8AB9BQ33354547-4FC48BC1-9496-4573-A77A-F14890F85E9DQ35018514-6446CB62-AA5F-418A-AB65-350E3316CA04Q36153422-87E336CF-602D-4F31-8601-D86D9064993BQ36200300-FFF76B46-5CD6-45AF-9E93-93490271D0C9Q36407239-EDA6AB0C-797F-4B31-A055-855D8CCA8539Q36734284-BF9408CE-260A-4EEC-AE36-E803932D9C38Q37386171-2AB2D925-213E-46A5-913A-7F9F2E0B2A12Q37437233-66DECEDC-01BE-491C-9DAC-EBDE86C0D890Q37927089-100C28BC-D5BC-4E68-8165-34626DF922F9Q38810295-1AC343ED-7907-40C9-8EC5-F35CFE9404EAQ39100115-E1BCF1EF-2425-435F-9CD1-F0C5AF0D8A0BQ39282600-047B7189-42E9-4EAF-A203-59B6946FDEF7Q39448700-1D281D17-6879-48A0-BE67-6860859A0FAAQ40519542-8CC72CCD-388D-471A-B9C7-01A696DDE696Q41847123-1442E01B-E2DB-4123-A9DF-39E3670D9B85Q42005573-3D1D29CD-E05A-4F6C-8EA9-FF1505A38819Q42729095-68335C16-972A-4B3B-ADB2-ECCC7B4AE4CBQ42785026-CF9F2BFD-8B6B-4CD5-84B8-127FB0D66AE7Q43188286-19E513C8-39DF-483E-89D2-8B858D8EDFB5Q45394555-ED8E7883-B1D8-4869-ACFA-4E0F084BD2D9Q46549470-FFE99DEE-AA5D-4820-84DE-5588FE8E0925Q46701464-010296DE-BB0B-4A56-A768-D017B33294DFQ47982466-CD82FBDB-A4C7-4AFD-B5D9-8AAE8B3E0799Q54364092-A2A79CB4-7CE1-4BFC-A41A-ED224FE71022Q57795857-C2EF9F02-260D-4349-A10C-5428FA82A837Q58416097-B2905292-42FC-4EB3-9ACF-20750E881EBF
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Flt3 mutations and leukaemia.
@ast
Flt3 mutations and leukaemia.
@en
type
label
Flt3 mutations and leukaemia.
@ast
Flt3 mutations and leukaemia.
@en
prefLabel
Flt3 mutations and leukaemia.
@ast
Flt3 mutations and leukaemia.
@en
P2093
P2860
P1476
Flt3 mutations and leukaemia.
@en
P2093
David C Linch
Panagiotis D Kottaridis
Rosemary E Gale
P2860
P304
P356
10.1046/J.1365-2141.2003.04500.X
P407
P577
2003-08-01T00:00:00Z